| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10. | INTELLIGENT BIO SOLUTIONS INC. - 10-K/A, Annual Report | 8 | SEC Filings | ||
| 13.10. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 11.09. | Intelligent Bio Solutions meldet höhere Aktienzahl nach Ausübung von Optionsscheinen | 2 | Investing.com Deutsch | ||
| 10.09. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET | 2 | GlobeNewswire (USA) | ||
| 09.09. | Intelligent Bio Solutions submits FDA application for codeine test | 1 | Investing.com | ||
| 09.09. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | - | SEC Filings | ||
| 09.09. | Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market | 2 | Benzinga.com | ||
| 09.09. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance | 296 | GlobeNewswire (Europe) | NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 04.09. | Intelligent Bio Solutions Secures Up To $15 Million Private Placement | 4 | pulse2.com | ||
| 01.09. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission | 239 | GlobeNewswire (Europe) | NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 28.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 20.08. | Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M | 5 | Seeking Alpha | ||
| 19.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth | 453 | GlobeNewswire (Europe) | Reader installed base grew 22% year-over-year, driving a 35% increase in total consumable cartridges to over 100,000 units Full year gross profit margin expanded to 48.63%, up 778 basis points year-over-year... ► Artikel lesen | |
| 19.08. | INTELLIGENT BIO SOLUTIONS INC. - 10-K, Annual Report | 3 | SEC Filings | ||
| 17.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification | 284 | GlobeNewswire (Europe) | NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 11.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 5 | SEC Filings | ||
| 11.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System | 4 | GlobeNewswire (USA) | ||
| 05.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission | 223 | GlobeNewswire (Europe) | NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 03.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,220 | -0,60 % | Eckert & Ziegler erhält Herstellungserlaubnis für Actinium-225 | Eckert & Ziegler hat für die Produktion des radioaktiven Isotops Actinium-225 (Ac-225) eine Herstellungserlaubnis nach den Vorgaben der Guten Herstellungspraxis (GMP) erhalten. Die zuständige deutsche... ► Artikel lesen | |
| DRAEGERWERK | 105,40 | +0,76 % | Was jetzt entscheidend wird bei Desert Gold, Draegerwerk und Verbio | Erstellt und veröffentlicht im Auftrag von Desert Gold Ventures Inc. Starke Kursbewegungen, operative Meilensteine und veränderte Gewinnperspektiven prägen derzeit das Bild bei drei sehr unterschiedlichen... ► Artikel lesen | |
| TELADOC HEALTH | 7,762 | -0,41 % | Stifel hebt Kursziel für Teladoc Health an: Kostensenkungen stärken Margen | ||
| HIMS & HERS HEALTH | 25,780 | -0,46 % | Novo Nordisk, Eli Lilly oder Hims & Hers: Welche Abnehmspritzen-Aktie im Trend-Check vorne liegt - Jetzt lesen! | ||
| BICO GROUP | 2,205 | +0,46 % | Cellink mit EILMELDUNG: Folgt jetzt der nächste Kursrutsch? - Jetzt handeln, noch vor Börsenschluss! | ||
| SERNOVA BIOTHERAPEUTICS | 0,075 | +8,43 % | Sernova Biotherapeutics mit EILMELDUNG: Könnte die Aktie nach 33,3 % Plus jetzt komplett durchstarten? - Handeln Sie, bevor es zu spät ist! | ||
| GERATHERM MEDICAL | 2,110 | -3,21 % | Geratherm Medical Aktie: Der Umbau soll die Wende bringen | Geratherm Medical steckt operativ weiter in einer schwierigen Phase. Im ersten Halbjahr 2026 sank der Umsatz um 12,5 Prozent auf 7,0 Millionen Euro, während das EBIT auf minus 0,5 Millionen Euro zurückging.... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 139,00 | +0,83 % | Ihre wichtigsten Termine: Apple, Ebay, Microsoft, Alphabet, Biogen und Boston Scientific legen Zahlen vor! | © Foto: Andrej Sokolow - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0162551016... ► Artikel lesen | |
| SYNLAB | - | - | Cizzle Biotechnology - Cizzle presents at SYNLAB Innovation Symposium | ||
| CERENOME | 1,460 | +4,73 % | Cerenome completes enrollment in glioblastoma drug trial | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| HEALWELL AI | 0,420 | -3,00 % | WELL Health Technologies Corp.: WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter | Vancouver, British Columbia and Toronto, Ontario--(Newsfile Corp. - October 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,120 | +6,53 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SPINEWAY | 0,085 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report |